Viewing Study NCT01812759

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:27 PM
Ignite Modification Date: 2026-01-01 @ 8:03 PM
Study NCT ID: NCT01812759
Status: TERMINATED
Last Update Posted: 2021-06-29
First Post: 2013-03-14
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Fentanyl for Breakthrough Pain in the Emergency Department
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pain View
None Breakthrough cancer pain View
None Emergency Department View
None ED View
None Fentanyl nasal spray View
None Lazanda View
None Placebo nasal spray View
None Hydromorphone PCA View
None Dilaudid View